Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle H S Kuan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology|February 16, 2020
The pharmacokinetics of metformin in patients receiving intermittent haemodialysisKlarissa A Sinnappah, Isabelle H S Kuan, Tilenka R J Thynne, et al.
Clinical Pharmacokinetics|December 13, 2016
A Population Pharmacokinetic Model for <sup>51</sup>Cr EDTA to Estimate Renal FunctionIsabelle H S Kuan, Stephen B Duffull, Tracey L Putt, et al.
British Journal of Clinical Pharmacology|May 18, 2021
Does the intact nephron hypothesis provide a reasonable model for metformin dosing in chronic kidney disease?Sudeep Pradhan, Stephen B Duffull, Luke C Wilson, et al.
Plos One|February 18, 2021
Metformin doses to ensure efficacy and safety in patients with reduced kidney functionIsabelle H S Kuan, Luke C Wilson, Jed C Leishman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology|February 16, 2020
The pharmacokinetics of metformin in patients receiving intermittent haemodialysisKlarissa A Sinnappah, Isabelle H S Kuan, Tilenka R J Thynne, et al.
Clinical Pharmacokinetics|December 13, 2016
A Population Pharmacokinetic Model for <sup>51</sup>Cr EDTA to Estimate Renal FunctionIsabelle H S Kuan, Stephen B Duffull, Tracey L Putt, et al.
British Journal of Clinical Pharmacology|May 18, 2021
Does the intact nephron hypothesis provide a reasonable model for metformin dosing in chronic kidney disease?Sudeep Pradhan, Stephen B Duffull, Luke C Wilson, et al.
Plos One|February 18, 2021
Metformin doses to ensure efficacy and safety in patients with reduced kidney functionIsabelle H S Kuan, Luke C Wilson, Jed C Leishman, et al.
Pageof 1